doi: 10.1161/CIRCRESAHA.120.315937 3 AdakA.KhanM
However, there are also reports of ketamine-induced liver injury in the clinical setting
Although rare, ION has recently been linked to GLP-1 receptor agonists, particularly semaglutide, marketed as Wegovy, Ozempic, and Rybelsus, and variously used to treat obesity, diabetes, and to reduce cardiovascular disease risk, according to a team of Canadian researchers from the universities of Ottawa, Calgary, and Toronto."Semaglutide, in any formulation, was the only agent significantly associated with ION, with the strongest signal for Wegovy, followed by Ozempic, the researchers said in the paper
In the following part, we will describe the different vaccine-based strategies of senotherapeutics that have been studied, and we will show the limitations of some of them to be used into clinics